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PENDARAHAN INTRAVENTICULAR: KADAR KELAZIMAN DAN 
FAKTOR RISIKO DI KALANGAN BAYI YANG DILAHIRKAN 
PADA USIA KANDUNGAN KURANG DARI 32 MINGGU DI 
DALAM MALAYSIAN NEONATAL REGISTRY (2008 -2011) 
ABSTRAK 
Pengenalan 
Pendarahan dalam ventrikel otak adalah merupakan salah satu penyebab 
utama kecacatan neurologi di kalangan bayi pramatang dan menyumbang kepada 
kematian dan kesan jangkapanjang. Tujuan utama kajian ini adalah untuk 
menentukan kadar kelaziman dan faktor-faktor yang berkaitan dengan masalah 
pendarahan dalaman ventrikel di kalangan bayi yang dimasukkan ke unit rawatan 
rapi neonatal yang didaftarkan di Pendaftar Neonatal Kebangsaan di Malaysia 
(Malaysian Neonatal Registry) dari 2008 – 2011. 
Objektif: 
Objektif umum: 
Untuk menentukan kadar kelaziman masalah pendarahan dalaman ventrikel otak dan 
faktor-faktor berkaitan di kalangan bayi pramatang di Malaysia. 
Objektif spesifik: 
Untuk menentukan kadar perubahan pada pemeriksaan ultrasonografi kranium dari 
tahun 2008 hingga 2011. 
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Untuk menentukan kadar kelaziman secara keseluruhan masalah pendarahan 
dalaman ventrikel otak di hospital-hospital yang berdaftar dengan Pendaftar Neonatal 
Kebangsaan di Malaysia dari tahun 2008 hingga 2011. 
Untuk membandingkan kadar masalah pendarahan dalam ventrikel di antara hospital 
yang berdaftar dengan Pendaftar Neonatal Kebangsaan daripada tahun 2008 hingga 
2011. 
Untuk menentukan faktor-faktor risiko berkaitan yang menyebabkan pendarahan 
dalaman ventrikel otak di kalangan bayi pramatang yang lahir pada usia kandungan 
kurang daripada 32 minggu yang dimasukkan ke unit rawatan rapi neonatal di 
Malaysia daripada 2008 hingga 2011. 
Kaedah Kajian: 
Kaedah yang digunakan adalah kajian lintang. Data daripada 36 buah hospital 
di Malaysia yang berdaftar dengan Pendaftar Neonatal Kebangsaan dari tahun 2008 
hingga 2011 telah dianalisis menggunakan pengkalan data elektronik. Kriteria 
kemasukan ke dalam kajian adalah bayi yang lahir pada umur kandungan kurang 
daripada 32 minggu dan berat semasa lahir adalah kurang 1500 gram.  Pranatal, cara 
kelahiran dan perkara yang berlaku semasa neonatal dianalisis. Ultrasonografi 
kranium adalah cara yang digunakan untuk memastikan diagnosa pendarahan dalam 
ventrikel. Data telah dimasukkan dan dianalisis menggunakan perisian SPSS versi 
22.0.  Data mengikut kategori telah diterjemah dalam bentuk frekuensi, peratusan 
dan pembandingan telah dilakukan menggunakan chi-square test. Tahap signifikan 
yang digunakan adalah nilai p<0.05.  Analisi deskriptif telah digunakan untuk 
menentukan kadar kelaziman pendarahan dalam ventrikel di kalangan bayi pra-
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matang. Analisis regrasi mudah dan berganda telah digunakan untuk menentukan 
faktor-faktor penyumbang kepada masalah ini. 
Hasil Dapatan Kajian: 
Jumlah bayi yang telah menyertai kajian adalah 10927 dan kadar kelaziman 
masalah pendarahan dalaman ventrikel otak secara keseluruhan bagi bayi yang telah 
menjalani pemeriksaan ultrasonografi kranium adalah 39.5%. Secara keseluruhan, 
85.4% bayi yang terlibat telah menjalani pemeriksaan ultrasonografi kranium ini. 
Peratusan mengikut tahap keseriusan perdarahan adalah Tahap I sebanyak 13.7%, 
Tahap II adalah 12%, Tahap III adalah 8.7% dan Tahap IV adalah 4.9%. Tahap yang 
serius (Tahap III dan IV) adalah tinggi di kalangan bayi yang lahir pada umur 
kandung antara 22 hingga 25 minggu (32.7%) dan berat semasa lahir di antara 500 
hingga 750 gram (29.7%). 
Kadar kelaziman mengikut lokaliti hospital pula adalah 40% di hospital-
hospital yang terletak di Malaysia Timur, 38% di Pantai Barat Semenanjung 
Malaysia dan 36% di Pantai Timur Semenanjung Malaysia, dengan nilai p>0.05. 
Analisis regrasi berganda menunjukkan umur kandungan yang kurang 
matang, kurang berat masa kelahiran, ventilasi secara konvensional, HFOV, 
pneumothorax, PDA, NEC dan infeksi merupakan pembolehubah tidak bersandar 
yang signifikan yang berhubungkait dengan masalah pendarahan dalaman ventrikel. 
Kesimpulan: 
Kadar kelaziman pendarahan dalaman ventrikel di kalangan bayi pra-matang yang 
terlibat dengan kajian ini adalah 39.5%. Umur kandungan yang kurang matang, 
   vii  
  
kurang berat semasa lahir, ventilasi secara kovensional, HFOV, pneumothorax, PDA, 
NEC, nCPAP, ibu berpenyakit kencing manis dan infeksi boleh dikira sebagai faktor 
utama penyebab kepada masalah ini berlaku. 
  
  viii  
  
INTRAVENTRICULAR HAEMORRHAGE: PREVALENCE AND RISK 
FACTORS IN BABIES BORN WITH GESTATIONAL AGE LESS THAN 32 
WEEKS IN MALAYSIAN NATIONAL NEONATAL REGISTRY (2008 – 2011) 
 (2008 – 2011) 
ABSTRACT 
Introduction 
Intraventricular haemorrhage (IVH) is a major cause of neurological 
disabilities in prematures babies, an important cause of mortality and long-term 
morbidity. This study aimed to determine the prevalence and factors associated with 
IVH among Malaysian neonates admitted to neonatal intensive care units (NICUs) 
which participated in Malaysian National Neonatal Registry (MNNR) from 2008-
2011. 
Objective  
General objective: 
To determine the prevalence of IVH and associated risk factors among premature 
babies in Malaysia. 
Specific objective:  
To determine the overall prevalence of IVH in hospitals participated in the MNNR 
from 2008-2011. 
   ix  
  
To compare the prevalence of IVH between the hospitals participated in the MNNR 
from 2008-2011. 
To determine the associated risk factors of IVH among preterm infants < 32 weeks 
admitted to Malaysian NICUs from 2008-2011  
To determine the changes in cranial ultrasound (CUS) performed from 2008-2011. 
 
Methods: 
This was a cross sectional study. Data from 36 Malaysian hospitals 
participated in MNNR 2008-2011 electronic database was analysed. The inclusion 
criteria included neonates with gestational age (GA) < 32 weeks and birth weight 
(BW) ≤ 1500 grams. Prenatal, delivery characteristic and neonatal events were 
analysed. Cranial ultrasonography (CUS) was the modality to diagnose IVH. Data 
entry and analysis conducted using SPSS for window version 22.0. Categorical data 
were expressed in frequency, percentage, and comparison made using the chi-square 
test. The level of significance used was p <0.05. Descriptive analysis was done to 
determine the prevalence of IVH among premature babies.  Simple and multiple 
logistic regression analysis were used to determine the associated factors of IVH.  
Results: 
The total babies recruited were 10927 and the prevalence of IVH (overall) in 
babies whom CUS performed was about 39.5%. Overall, CUS was performed in 
85.4% babies. Grade I IVH was 13.7%, Grade II was 12%, Grade III was 8.7% and 
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Grade IV was 4.9%. The prevalence of severe IVH (grade III & IV) was highest in 
the smallest groups i.e. the GA group 22 - 25 weeks (32.7%) and BW group 500 – 
750gram (29.7%). Prevalence of IVH in East Malaysia hospitals was 40%, West 
Coast hospitals were 38% and East Coast hospitals was 36 %, p > 0.05. 
Multiple logistic regression analysis showed that lower GA, lower BW, 
conventional ventilation, HFOV, pneumothorax, PDA, NEC and infection were 
significant independent variables associated with IVH 
Conclusion: 
The prevalence IVH among the studied premature babies was 39.5%. Lower 
GA, BW, conventional ventilation, HFOV, pneumothorax, PDA, NEC, n CPAP, lack 
of antenatal steroid, maternal diabetic and infection were considered the main 
associated risk factor with IVH. 
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CHAPTER 1 
                                             INTRODUCTION 
1.1  Background of the study  
Intraventricular haemorrhage (IVH) is an important cause of mortality and 
long-term morbidity in preterm babies (Bassan, 2009). The global incidence of IVH 
has declined from 50% - 80% (1980) to  10% - 40%  (2010s)  (Lee et al., 2010b) . 
The incidence of IVH varied among different nations (Behrman and Butler, 2007). 
Because of the persistently relatively high incidence of IVH and the significant 
financial and societal burden of this disease, many postnatal medical prevention 
strategies have been explored (McCrea and Ment, 2008). The prevalence of IVH has 
decreased gradually in developed countries during the last decade when comparing 
with developing countries. There are very a few studies from developing countries. 
Antenatal steroids have been proven to be beneficial in preventing 
complications related to premature delivery. As the use of antenatal corticosteroids 
increases from 24% to 87% (Stoll et al., 2015), the morbidity and mortality rates in 
premature babies decreases. Large randomized studies have revealed a 50% 
reduction in the incidence of Respiratory distress syndrome (RDS) following 
administration of antenatal corticosteroids, in addition to other complications such as 
severe IVH and necrotizing enterocolitis (NEC) (Roberts, 2010).  
Prematurity is the most important clinical problem in obstetrics and neonatal 
medicine (Blencowe et al., 2013b). The costs of managing these premature babies 
are very high – not only during the initial neonatal treatment but also after discharge 
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from the neonatal unit and the financial burden on the family tends to be large (Dalili 
et al., 2014) . Neonates born too early, especially those with very low gestational age 
(GA) are at risk to develop IVH, which is often complicated with cerebral palsy, 
mental retardation and disability (Allen, 2008). 
Cranial ultrasound (CUS) is an excellent instrument to detect the most 
common brain abnormalities in preterm and full-term neonates, to study the 
evolution of lesions and to follow brain maturation  (van Wezel-Meijler et al., 
2010a). With the availability of portable ultrasound machine in many NICUs, it is 
technically much easier to image the neonatal brain repeatedly even in the most 
sickest premature neonates.  (Leijser et al., 2006). 
A thorough literature search did not yield large studies in Malaysia 
determining the incidence and importance of individual risk factors for IVH in 
preterm babies. That is why this study was undertaken with the objectives to assess 
the incidence of and the importance of individual risk factors for IVH in Malaysian 
tertiary hospitals. 
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1.2  Prematurity 
Preterm birth is an important perinatal health problem in the world. In 2010, 
expected 14·9 million babies (uncertainty variety 12·3–18·1 million) babies were 
born too early, representing a preterm birth rate of 11.1%. The percentage of preterm 
deliveries varies depending on the geographical location (Blencowe et al., 2013a). 
The developing countries in Sub-Saharan Africa and South Asia account for half the 
world‘s births, more than 60% of the world‘s preterm births. Over 80% of the 
children‘s mortality (1.1 million deaths) are due to preterm birth complications 
(Lawn et al., 2013). The cause of the highest number of the deaths within the first 7 
days after birth is not congenital malformations, but preterm birth (Beck et al., 2010). 
Most important improvements in perinatal management, including antenatal 
corticosteroids, early surfactant usage, and high technology for pre- and postnatal 
care and monitoring, can improve the survival rates of very preterm babies (Israel, 
2011). 
Preterm birth is defined by the WHO as delivery before 37 completed weeks 
or 259 days of gestation.  Based on gestational age (GA), prematurity is further 
divided into the following sub-groups: Extremely preterm - GA < 28weeks; very 
preterm: GA 28 to 32 weeks; moderate to late preterm - GA 32 to 37 weeks  (Tucker 
and McGuire, 2009) . 
There is also another classification for premature babies, according to birth weight 
(BW). The extremely low birth weight (ELBW) are babies born with BW  ≤ 1000g, 
infants born with a weight between 1000 and 1500 g are termed very low birth 
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weight (VLBW), and those with birth weight between 1500 g  and 2500 g are 
classified as low birth weight (LBW) (Tucker and McGuire, 2009) (WHO, 2011).  
Preterm birth is still not understood, and the aetiology is multi-factorial. 
Contributing risk factors related to preterm delivery include medical conditions of 
short interval between pregnancies, previous preterm birth, occupation and 
educational level, low socioeconomic status , infertility treatments and genetic 
influences (Goldenberg et al., 2008; Muglia and Katz, 2010; Raisanen et al., 2013). 
Preterm birth is really a global problem. In the lower-income countries, 12% of 
babies are born early compared with 9% in higher-income countries. In general 
poorer societies are at higher risk (Organization, 2015). Around 9.6% (12.9 million) 
births globally are preterm, the prevalence of preterm and low BW (LBW) births in 
the United States is estimated at 8.2% per year (Soleimani et al., 2014). In some 
European countries, the prevalence of preterm delivery continue to plateau or 
decreased between 1996 and 2008 (Zeitlin et al. 2013). The United States had a 
higher infant mortality rate when compared with Europe (Mac Dorman & Mathews, 
2010). In addition to dissimilarity in mortality rates between countries, there are also 
disparities between races. In a study done by Blencowe in 2009, it was shown that 
the preterm birth rates were 11% in white Americans and 18 % in black Americans. 
Women younger than 17 years or older than 40 years had more prematurity than 
other age groups (Blencowe et al. 2012). 
In Malaysia, a study in Hospital Kuala Lumpur in 1991, revealed the 
prevalence of LBW was 13.5% 
 
but these babies contributed to 74.8% of all deaths 
(Tahir et al., 1991). Another study in Hospital Seremban, in 2008 found a prevalence 
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of LBW infants as13.96%. Recent data analysis by Department of Statistics 
Malaysia, Putrajaya in 2011 showed a prevalence of LBW in the Malaysian 
population of 11% (Sutan et al., 2014).  
In the last decades, the survival rate of premature babies has increased 
markedly, despite the growing number of live born VLBW infants. Unfortunately, 
the incidence of neuro-developmental complications remained high among these 
premature survivors. The most common brain damage among premature infants 
includes IVH which was the main topic of this study, post-haemorrhagic 
hydrocephalus (PHH), and periventricular leukomalacia (PVL) (Volpe, 2001). 
Almost all major organ systems are immature in preterm babies. There are 
many respiratory complications associated with prematurity such as respiratory 
distress syndrome (RDS) (Stoll et al. 2010) and bronchopulmonary dysplasia (BPD) 
(Bhandari & McGrath-Morrow 2013). Gastrointestinal immaturity is also a common 
problem of prematurity, leading to mild feeding intolerance to the most severe 
complications such as NEC in about 5% to 10% (Schulzke et al. 2007). Patent ductus 
arteriosus (PDA), is the most common complications of the heart (Hamrick & 
Hansmann 2010). Sepsis is another very common problem of preterm infants (Saigal 
and Doyle, 2008). 
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1.3  Intraventricular haemorrhage  
Intraventricular haemorrhage (IVH) is the main common variety of neonatal 
intracranial haemorrhages. It starts as bleeding originating from the germinal matrix 
and spreads from there under the ependymal lining of the lateral ventricles (grade I). 
When the ependymal layer gives way, the blood enters the ventricle (grade II) and if 
severe it may cause dilatation of the ventricle (grade III). The most severe IVH is 
characterized by blood breaking through the ventricle wall into the parenchyma of 
the brain, intraparenchymal bleeding or grade IV. This grading of IVH is based on 
the Papile classification system (Papile, 1978). The presence of severe IVH (grade III 
or IV) had strong association with motor impairment (Futagi, 2006).The grading and 
causality of IVH is discussed further below.   
IVH is an important cause of morbidity and mortality in VLBW and ELBW 
infants and a main cause of neurological impairment and severe cognitive deficit in 
low BW infants. Even though technology and quality of care in NICUs around the 
world have progressed tremendously, it is still an important cause of morbidity. 
There are two main reasons first, the incidence is directly associated with the degree 
of prematurity and second, the percentage of premature infants surviving has 
increased steadily (Kim et al., 2014). In other words, neuroprotection for premature 
infants remains a main concern because many VLBW and ELBW babies, who would 
have died decades, previously tend to survive now. Specific treatments for IVH 
remain limited (Allen, 2013). The causes of IVH are multifactorial and are primarily 
related to intrinsic weakness of the germinal matrix vasculature and due to instability 
of cerebral blood flow. Even though the different grades of IVH have been referred 
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to in the text above while discussing the progression of an IVH, the classification is 
given in a more schematic way, below: 
 Grade I: germinal matrix haemorrhage. 
 Grade II: IVH without distension of the ventricular system.  
 Grade III: blood heavy and distending the ventricular system. 
 Grade IV: parenchymal involvement of haemorrhage (Papile et al., 
1978)  
There had been a decline in the incidence of IVH since the 1980s, the rate 
ranging between 50% and 80% during that time. In the early 2000s the incidence had 
reduced to 10% to 15%. The survival rate of extremely preterm babies has increased, 
but IVH remains a main problem in newborn (Volpe, 2001). 
Lee in 2010 reported that the incidence ranged from 15% to 40%, and that the 
variation was big among different countries (Lee et al. in 2010). Identifying the most 
important risk factors and knowing the underlying causes of IVH have potential to 
allow the development of better strategies for prevention of many neurodevelopment 
complications of preterm babies. Prenatal risk factors such as low GA, low BW, 
vaginal delivery, low Apgar score, intrauterine infection, and metabolic acidosis, 
early onset sepsis have been proposed to be associated with the pathogenesis of IVH 
(Lee et al. in 2010). Other suggested risk factors for IVH include temperature 
instability (hypothermia and hyperthermia), apnoea, feeding problems, bradycardia, 
hypoglycaemia and hyperglycaemia (Walker, 2013). Laboratory findings such as 
leucocytosis, leukopenia, thrombocytopenia and elevated C- reactive protein, (even if 
there is negative blood culture) have been proposed as risk factors  (Osborn et al., 
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2003; Vural et al., 2007). Another study also identified other risk factors e.g. 
prolonged resuscitation, hypotension and the presence of clinical features as 
respiratory distress syndrome, seizures, pneumothorax, decreased urine output, and 
NEC (Cloherty et al., 2008). Some risk factors for IVH are related to maternal illness 
e.g. maternal diabetes mellitus (gestational and presentational diabetes mellitus), 
preeclampsia, premature rupture of the membranes (PROM), and oligohydramnios 
(Tioseco et al., 2006). 
The most common way for diagnosis of IVH is cranial ultrasound (CUS) that 
is used routinely in premature babies for screening IVH, (Ment et al., 2002). CUS 
has been used to diagnose IVH since the late70s. Although MRI is increasingly being 
used, CUS is the most readily presented and commonly used neuro-imaging 
technique in the Neonatal intensive care unit (NICU) (Brouwer et al., 2014). Serial 
CUS appears highly effective in diagnosing the brain insult in preterm babies, even 
though it may miss cerebellar abnormalities. MRI does recognize these lesions, but 
its practicality is limited (Brouwer et al., 2014). It has been reported that 90% of 
IVHs occur within the first 3 days after birth. Lumbar puncture is another diagnostic 
procedure that can be used to detect IVH (Volpe, 2001). 
Fifty percent to seventy five percent (50% to 75%) of preterm survivors with 
severe IVH have been reported to progress to hydrocephalus, cerebral palsy, and 
mental retardation. A quarter of the nondisabled survivors developed psychiatric 
problems with executive function (Indredavik et al., 2010). In the neonatal age 5 – 10 
% of preterm babies with severe grades of IVH mostly manifested with seizures and 
post haemorrhagic hydrocephalus and high mortality (McCrea and Ment, 2008).IVH 
is often associated with periventricular leukomalacia (PVL)(Ballabh, 2010). 
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1.4  Malaysian National Neonatal Registry (MNNR) 
1.4.1 Structure 
The MNNR consist of an Advisory Board, the Steering Committee members 
and administrative staff. The Advisory Board, consisting of senior neonatologists and 
some members of the Steering Committee, supervises and observes the direction of 
the registry. The Steering Committee consists of a nine members involving 
neonatologists and a geneticist of participating hospitals and from the Universities. 
This committee serves to manage, complete and monitor the functions of MNNR and 
it meets as a minimum, three times a year. 
1.4.2 History 
At a National Paediatrician‘s meeting in October 2001, it was decided that a 
registry should be started with the aim to study the outcome of sick babies who were 
admitted to NICU to Malaysia Hospitals. It is known that a data collection system at 
national level can help individual NICUs to identify their own strengths and 
weaknesses in direct comparison with similar units delivering similar care. This is 
likely to reduce mortality and morbidity of infants.  
A first study was done from 1st October to 31st December 2002, in about 14 centres 
with cooperation of the Clinical Research Centre (CRC), Ministry of Health of 
Malaysia.  In October 2003, a report of this study was published. It was established 
that the NNR was practically possible and it was suggested that it could be beneficial 
for the clinical management and policy development. MNNR proper then began in 
January 1, 2004, and the first reports for the years 2004 and 2005 were published 
(http://www.acrm.org.my/mnnr/). 
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1.4.3  Registration criteria 
MNNR is a critical review of selected infants transferred to the neonatal 
intensive care unit (NICU). This includes: 
A. All new born admitted to a NICU who 
 1. had a gestation of < 32 weeks Up to 31 weeks of +6 days) 
 2. had a birth weight of 1500 grams and less. 
  3. Who was ventilated 
  4. With a major congenital abnormality 
  5. With a hypoxic ischemic encephalopathy 
B. All new born babies (<28days) deaths who died in the NICU, labour room, 
operating theatre and other wards. Inborn and out born babies will be included except 
out born babies who expire before arrival. Exclusion from study babies who  are at a 
corrected gestation of > 44/52 (http://www.acrm.org.my/mnnr/). 
1.4.4 The Malaysian Neonatal Registry aims to: 
 Determine the frequency and distribution of sick new born in 
Malaysia.  
 Study the mortality and morbidities of newborn who admitted to the 
NICU.  
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 Estimate the mortality rates of perinatal, neonatal, and stillbirth inborn 
babies. 
 Match and register the outcomes between different centres. 
 Improve the indicators of standard care in numerous areas.  
 Study consequences of VLBW babies. 
 Encourage and simplifying research on the neonatal serious disorders 
and their management (http://www.acrm.org.my/mnnr) 
1) There is some report published to the MNNR in the Figure:  0.1 
2003 2004 2005 
   
 
Report of Pilot Study - 
October to December 2002  
 
Report of the Malaysian  
National Neonatal Registry 2004 
 
Report of the Malaysian  
National Neonatal Registry 2005 
2006 2007 2008 
   
 
Report of the Malaysian  
National Neonatal Registry 2006 
 
Report of the Malaysian 
National Neonatal Registry 2007 
 
Report of the Malaysian 
National Neonatal Registry 2008 
Figure ‎0.1: Reports published to the Malaysia national neonatal registry 
Source :( http://www.acrm.org.my/mnnr) Approval from the Steering committee of the MNNR (Appendix B)
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CHAPTER 2 
LITERATURE REVIEW 
2.1  Prevalence of intraventricular haemorrhage 
In recent years, the incidence of IVH, range from 15% - 40 %,according to different 
centre despite many efforts to reduce the incidence (Lee et al., 2010b). Data from 
multicentre surveys and neonatal networks presented that the incidence of IVH 
reduced to 25 % and 10 % in some European countries (Stichtenoth et al., 2012).  
Study was done in  Germany 2001 to 2005 reported the prevalence of IVH 
was 40%  all grades in premature babies who were (BW <1500 g or birth before 32 
weeks (Vogtmann et al., 2012). Dr. Stonestreet from Department of Paediatrics, 
Women & Infants' Hospital of Rhode Island, USA  reported in 2006 the incidence of 
all types of IVH was 36% with severe types (Grades III and IV) 14 % for premature 
babies with BWT <1000 g (Stonestreet, 2009). 
A study done in Mofid Hospital NICU Tehran, Iran  by Sajjadian, in 2010 
reported an overall incidence of IVH of 64.4%, grade I was 40%, and grade II 
was11%, III 25.7% and  VI was 2.8% (Sajjadian et al., 2010). Rong, 2012 reported 
the overall incidence of IVH was 3.9 % for all preterm babies in Wuhan, China. The 
incidence of IVH increased with decreasing GA. For GA of 35–37 weeks, it was 1.93 
% and for GA < 30 weeks, it was up to 36.0 %  (Rong et al., 2012). 
Mohamed reported in this study at the United States from 1998 to 2004, 
included more than 1000 hospitals, the overall prevalence of IVH was 14.7% and the 
overall mortality was 24.5% and 46% of the babies (<1000 g) at birth with IVH 
(Mohamed and Aly, 2010).  
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 A study done at NICU of Seoul National University Children's Hospital 
between June 2003 and December 2007, the incidence of IVH overall was 27.8%. 
Among all babies and 79.7% had grade I , 6.9% had grade II, 4.8% had grade III, and 
8.6% had grade IV(Lee et al., 2010b). Another study by Stoll this study were 
collected the extremely low GA (22–28 weeks) and very low BW (401–1500 g) 
between January 1, 2003, and December 31, 2007 ,they showed the incidence of IVH 
declining from 2003 to 2007( 22.1% to 10.5%). The IVH grading were  grade I was 
10% grade II was 6, grade III was 7 % and grade IV was 9 (Stoll, Hansen et al. 
2010).   
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2.2  Pathogenesis of intraventricular hemorrhage 
2.2.1 Germinal matrix vasculature fragility 
The germinal matrix (GM) is a richly vascularized, transient layer adjacent 
the ventricles. It produces neurons and glial cells, and is exists in the foetal brain 
between 8 and 36 weeks of gestation. It weakens at 25 weeks (Raets et al., 2013). 
GM vasculature is selectively susceptible to haemorrhage in premature babies during 
the first 48 hour of life. This recognized to be related to a rapid angiogenesis of this 
brain area, resulting in development of nascent vessels that result in a paucity of 
pericytes and immaturity of extracellular matrix (Billiards et al., 2006). 
Sonographically, germinal matrix haemorrhages show as sub ventricular 
echodensities changing into pseudocysts (Horsch et al., 2010).  
Premature infants predominantly bleed into the germinal matrix and not into 
the cortical layer. This may there is an intrinsic weakness in the germinal matrix 
vasculature compared to other parts of brain. Immaturity or weakness of the blood 
brain barrier (endothelial tight junctions, basement membrane, pericytes and 
astrocyte end-feet) can cause fragility of germinal matrix vasculature (Ballabh, 
2010). 
2.2.2 Disturbances in the cerebral blood flow  
The term ‗cerebral haemodynamic‘ includes cerebral blood flow (CBF), 
cerebral blood flow velocity, and cerebral blood volume (CBV). The prevention of 
disturbances in CBF and CBV is essential to prevent IVH. However, constant 
monitoring of CBF and CBV is still unreachable for clinical use. General information 
about the regulation of CBF and CBV is significant. Although the knowledge about 
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these factors is still inadequate, especially concerning auto-regulation and the exact 
role of CBV (Liem and Greisen, 2010).  Fluctuating CBF velocity during the first 
days after birth strongly correlates with the incidence of IVH. Elimination of this 
fluctuation in the CBF by intravenous Pancuronium infusion significantly reduced 
the incidence of IVH (Guzzetta et al., 1986). In premature babies with respiratory 
distress syndrome (RDS) IVH may be due to fluctuation in the CBF. Nevertheless, 
most of the neonatal units nowadays use synchronized ventilator modes, which 
reduce infants ―fighting‖ the ventilator and this may reduce fluctuations in the CBF 
velocity (Rennie et al., 1987). Besides this, routine use of neuromuscular blocking 
agents in ventilated babies is not recommended because of long-term neurological 
adverse effects. A Doppler technique can be used to measure CBF velocity in 
mechanically ventilated premature babies, with RDS (Ballabh, 2010). Some studies 
indicated that high CBF is associated with IVH whereas others described that low 
CBF is associated with increased risk of IVH (Tsuji et al., 2000).  
Other clinical conditions as patent ducts arteriosus, hypercarbia, hypotension, 
and restlessness also contribute to the instability in cerebral blood flow and therefore 
the development of IVH (Ballabh, 2010). There are factors that can lead to IVH by 
increasing the CBF, such as a rapid sodium bicarbonate infusion, which creates a 
high osmotic load and  a potential increase in arterial CO2, may  cause cerebral 
vasodilatation altering cerebral hemodynamic (Ballabh, 2010). In the preterm, the 
resting blood pressure has lower limits of auto regulatory volume than in term infants 
and numerous reports in sick preterm infants have shown diminished auto regulation 
(Wong et al., 2012). Instability of the cerebral blood flow can make rupture the 
vasculature.  
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Other clinical conditions as patent ducts arteriosus, hypercarbia, hypotension, 
and restlessness also contribute to the instability in cerebral blood flow and therefore 
the development of IVH (Ballabh, 2010). There are factors that can lead to IVH by 
increasing the CBF, such as a rapid sodium bicarbonate infusion, which creates a 
high osmotic load and  a potential increase in arterial CO2, may  cause cerebral 
vasodilatation altering cerebral hemodynamic (Ballabh, 2010). In the preterm, the 
resting blood pressure has lower limits of auto regulatory volume than in term infants 
and numerous reports in sick preterm infants have shown diminished auto regulation 
(Wong et al., 2012). Instability of the cerebral blood flow can make rupture the 
vasculature.  
2.2.3 Platelet and coagulation disorders  
The relationship between IVH and coagulation in the newborn has been an 
issue of debate. The role of low platelets in the aetiology of IVH is uncertain. In the 
absence of specific clinical situations known to lower platelets, Coen 2013 suggested 
that platelet concentrations fall because platelets are consumed when the vessels of 
the GMH rupture (Coen, 2013). Severe coagulation deficiency has long been 
considered a major contributing factor in the occurrence of  IVH in premature 
babies and severe grades of IVH has also been shown to happen together with severe 
derangement of coagulation in extremely low BW infants (Kuperman et al., 2011). It 
is generally considered advisable to keep the platelets above 100x 10
9
/L for the 
ELBW during the first week of life .The current usual therapy for newborns includes 
administration of vitamin K at the first day of life, in order to reduce the risk of 
haemorrhagic disease of the new born. On the other hand, IVH of preterm is still a 
major therapeutic challenge (Kuperman, 2013). 
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2.2.4 Genetic factors and intraventricular haemorrhage 
Genetic studies of IVH have mainly focused on gene complexes in 
inflammation and infection (Hallman, 2012). Genetic factors presentation may be 
independent risk factors of the same level as other known risk factors (Ramenghi et 
al., 2011). Mutations in coagulation, thrombophilia, and inflammation-related genes 
might contribute to the development of IVH (Szpecht et al., 2015). Premature babies 
who are carriers of the prothrombotic mutations are at increased risk for development 
of IVH. Un similar study by Göpel supposed the factor V Leiden and prothrombin 
G20210A gene mutations have a protective role against IVH that related to the 
improved coagulation attributable to the factor V Leiden and prothrombin G20210A 
(Göpel et al., 2001).Other different study done by Härtel et al establish no 
association between the prevalence of IVH in premature babies with BWT < 1500 
who were carrier of these mutations (Härtel et al., 2006). 
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2.3  Risk factors  
Some risk factors are associated with the development of IVH, including 
neonatal and maternal factors. Neonatal factors were explain with pathogenesis of 
IVH in Table 2.1  
Table ‎2.1:  Neonatal risk factors in the pathogenesis of intraventricular hemorrhage 
Major 
Pathogenic 
Mechanism 
Putative 
Mechanisms 
        Risk Factors Preventive Measures 
        
Disturbance in 
CBF 
Fluctuation in 
CBF 
 Suctioning and 
handling 
 No routine suctioning 
  
 
    
    
 Hypercarbia, hypoxia, 
acidosis 
 Optimize ventilation 
        
    
 Asynchrony between 
infants and ventilator 
breathe 
  
 Synchronized 
ventilation by the use 
of assist control 
    
       Synchronized 
      
 mandatory 
ventilation 
                       Modes 
        
     Severe RDS   
        
     Patent ductus arteriosis 
 Indomethacin 
/ibuprofen 
        
    
 Rapid infusion of 
NaHCO3  Slow infusion over 
extended period 
      
        
  
  
High cerebral 
venous 
pressure 
 Pneumothorax, high 
               ventilator pressure 
 Gentle ventilation 
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 Prolonged labour 
  
 Individualized 
approach as 
appropriate 
        
  
Abnormal 
blood pressure 
 Hypotension 
 As appropriate for 
the infant 
        
     Hypertension   
        
     Sepsis   
        
     Dehydration   
        
  
Pressure 
passive 
 Extreme prematurity 
and low birth weight 
(<1000 g) 
 As appropriate for 
infant 
circulation                the infant 
      
      
    
  
   Clinically unstable 
               resulting from 
                   Respiratory   
                  compromise, sepsis,   
                  or other reasons   
        
Inherent 
fragility of 
Might be 
worsened by 
 Hypoxic ischemic 
insult 
 Prenatal GCs 
stabilize 
germinal 
matrix 
an 
inflammatory 
 the microvasculature 
Vasculature 
injury to the 
BBB 
               by increasing: 
     Sepsis  1. Pericyte coverage 
      
 2. GFAP expression 
in 
                     Astrocytes 
      
 3. Fibronectin in 
basal  lamina 
        
Platelet and 
coagulation 
disturbances 
Haemostatic 
failure 
 Thrombocytopenia Replacement of blood 
   Disseminated Products 
                   Intravascular   
                   Coagulopathy   
        
Source Ballabh, Praveen. "Pathogenesis and prevention of intraventricular haemorrhage." Clinic perinatology 41.1 (2014): 
(Ballabh, 2014)
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2.3.1 Neonatal factors   
2.3.1.1 Low gestational age and low birth weight in neonate  
 Most mortality and morbidity affects ―very preterm‖ infants who those born 
before 32 weeks gestation and especially ―extremely preterm‖ infants who are born 
before 28 weeks of gestation. Over the past 20-30 years, advances in perinatal care 
have improved outcomes for infants (MacKay et al., 2010). A predictable 15 million 
babies delivered preterm every year. Approximately 1 million babies die each year 
because of complications of preterm birth. Many survivors spend a lifetime with 
disability, including learning disabilities and visual and hearing problems (WHO 
Preterm birth). 
Several studies have shown that low GA and low BW affect the risk of high 
grade IVH. Therefore, prevention of prematurity is likely the best way to prevent 
IVH. A program for prevention of prematurity must focus on early identification of 
women at risk, education about the causes of prematurity, early diagnosis and in 
utero transfer to a perinatal centre specializing of high-risk deliveries 
(Khodapanahandeh et al., 2008).  
Lee  determined that the perinatal risk factors  as a low BW and low GA are 
absolute major risk factors for IVH(Lee et al., 2010b). Low GA and asphyxia, as 
reﬂected by the Apgar scores, had an adverse effect on the incidence of severe IVH 
grades (Weintraub et al., 2001). Same results were obtained by Gleiβner  the risk of 
IVH was mostly connected to low GA (Gleiβner et al., 2000). 
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2.3.1.2 The Apgar score  
  The Apgar score is a screening examination worldwide used rapidly 
evaluates the health of newborn at one minute and five minutes after birth. The 1-
minute Apgar score measures how the newborn accepted the birthing progression. 
The 5-minute Apgar score assesses how fit the newborn is adapting to the 
environment. Virginia Apgar, M.D. (1909-1974) introduced the Apgar score in 1952 
(Apgar Score ADAM American Accreditation HealthCare Commission 2012). Each 
of five simply recognizable characteristics, respiration, heart rate, colour, reflex 
electability and muscle tone measured and assigned a value of 0 to 2.  Reliability of 
the Apgar in predicting outcomes of term babies has been a subject of controversy, at 
least for term babies. A continued scoring at 10 and 20 minutes in babies with poor 
Apgar scores seemed more reliable predictors of poor outcome than the early scores. 
Additional research is essential to recognize the threshold at which the Apgar score 
may best predict adverse outcomes (Malin et al., 2013).         
Many studies have documented the strong association between low Apgar 
score and risk of IVH in preterm babies. (Lee et al., 2010a). A study done at  Haifa, 
by Riskin (Riskin et al., 2008) showed that a low Apgar score at 1 min was 
significantly associated with IVH (OR 1.72 (1.33-2.21). Another study conducted in 
premature babies of GA< 32 weeks in a NICU in Isfahan, Iran from 2003-2005 
showed that low Apgar scores at 1 min (p =0.0014) & low Apgar scores at 5 min (p 
=0.005), had a strong association with the development of IVH (Badiee, 2007). 
Another study was done in Iran showed an association between low Apgar score at 5 
min and IVH (OR: 1.58; 95% CI: 1.5-6.32) (Khodapanahandeh et al., 2007). Lehner  
documented by multivariate analyses in a study at the University of Vienna hospital a 
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significant association between a 5-min Apgar score lower than seven (P=0.037) and 
severe IVH(Lehner et al., 2001). Study done by Vogtmann in Germany which 
showed that a low 1-minute Apgar score was closely related to IVH (Vogtmann et 
al., 2012). A large number of other studies in different parts of the world showed 
similar finding (Shankaran et al., 2014) (Synnes et al., 2001) (Osborn et al., 2003) 
(Weintraub et al., 2001). 
2.3.1.3 Respiratory distress syndrome 
 Respiratory distress syndrome (RDS) is an important cause of short- and 
long-term morbidity, and mortality worldwide. RDS was earlier identified as hyaline 
membrane disease in premature babies (van der Ham et al., 2012). In healthy 
newborns, the alveoli are small, air-exchanging sacs of the lungs layered by 
surfactant, which is soap-like material formed in the lungs when the foetus matures 
in preparation for birth. If premature babies have not yet formed enough surfactant, 
they are not capable to open their lungs to breathe fully. The risk of RDS increases 
with increasing prematurity (Reiss et al., 2003). A sixty percent chance of 
developing RDS was documented in babies who were born before 29 weeks of 
gestation (Vogtmann et al., 2012). Surfactant treatment for RDS became available in 
the 1990s. A series of surfactant studies showed conclusively a reduction in mortality 
and morbidities, and it is the standard of care for the treatment of RDS in preterm 
infants (Aftab and Gerdes, 2013). Study done by Khodapanahandeh showed that 
premature babies with RDS has risk to develop  IVH  (Khodapanahandeh et al., 
2008). Study was done by Sajjadian 2010 noted that 5% of premature babies who 
had respiratory distress associated with developed IVH (Sajjadian et al., 2010).  
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2.3.1.4 Respiratory support  
 Mechanical ventilation has a definite effect on survival of sick new-borns. 
Careful use of it can decrease the mortality and morbidity to a great degree. Positive 
pressure ventilators are the basis of providing mechanical ventilation in neonatal 
intensive care units (Nabi, 2005). Up to 50% of newborn treated in intensive care 
units were reported to require some type of mechanical respiratory support (Khemani 
et al., 2009; Wolfler et al., 2011).  
Current policies, aim to maintain and support spontaneous breathing and 
carefully avoid hypoxia and hypocapnia (Putensen et al., 2001). For lung protection 
relatively small tidal volumes and sufficient positive end-expiratory pressures 
(PEEP) are used (Jauncey-Cooke et al., 2010). These strategies have been shown to 
improve the neonatal outcome by improving gas exchange, reducing the duration of 
ventilator support and preventing ventilator-induced lung injury (Vanpee et al., 
2007). Early establishment of nCPAP in the management of RDS in premature 
babies, can significantly decrease the use of mechanical ventilation (MV) and 
surfactant therapy, which can reduce the complications (BalaJi et al., 2015). 
Ventilated neonatal breathing in asynchrony with the ventilator poses a threat 
of complications during mechanical ventilation, for example pneumothorax or IVH 
(Cools and Offringa, 2007). 
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2.3.1.5 Pneumothorax 
Pneumothorax is a life-threatening situation with high morbidity and 
mortality. It is defined as the occurrence of air between visceral and the parietal 
pleura (Antony, 2004). Pneumothorax is more common in the neonatal period and 
can arise spontaneously in non-ventilated babies It can be expected in premature 
babies if there is no improvement within a short time of resuscitation or if 
asymmetric chest movement is identified during resuscitation (Hill et al., 1982). 
Rapid diagnosis is required by urgent portable X-ray. Treatment consists of 
immediate intervention for life saving and better outcome (Hassan et al., 2015). New 
ventilator techniques have played a role in decreasing air leaks (Malek et al., 2011). 
Surfactant, and high-rate low-tidal-volume reduce the incidence of pneumothorax in 
VLBW (Vellanki et al., 2012). Numerous reports have indicated that pneumothorax 
is frequently associated with, or followed by IVH (Cooke et al., 1993). All 
pneumothorax produced by RDS can exacerbate or induce IVH (Pishva et al., 2012). 
2.3.1.6 Surfactant Therapy 
Exogenous surfactant replacement is considered the standard of care in the 
treatment of premature babies. Authors have called surfactant replacement therapy 
the best important discovery in paediatric medicine in the past 30 years (Thomas et 
al., 2014). Surfactant is a lipoprotein complex, originating in the lungs, which 
decreases alveolar collapse by developing a layer between the alveolar surface and 
the alveolar gas in the lungs, decreasing surface tension (Berry, 1991). Premature 
infants are not able to produce enough own surfactant because the type II alveolar 
epithelial cells are not matured. The alveoli may not inflate or collapse on expiration, 
